Enterprise Solutions

  1. Viral Vector CDMO Services From Design To GMP Delivery 10/26/2026

    Integrated viral vector development, testing, and GMP supply, paired with engineered plasmids and cell lines to reduce scale-up risk and improve yield.

  2. Single-Use Chromatography At Process Scale 10/23/2026

    Single-use chromatography at process scale, rebuilt around faster flow kit installation, barcode-driven batch records, and simpler automation connectivity, with a smaller manufacturing footprint.

  3. A Next-Generation System Designed To Improve Usability 10/23/2026

    The ÄKTA ready™ chromatography system has been redesigned as the SCS (standard configuration system) platform to meet current and future needs for batch manufacturing and intensified processing. SCS systems retain the benefits of single-use processing, with one-piece disposable flow paths that allow quick changeover and reduce the risk of carryover, while eliminating the need for cleaning between runs. The next-generation system is designed to improve usability for operators of all skill levels and to remove friction in your manufacturing process.

  4. Column Care Strategy And Buffer Preparation Support For Biologics Manufacturing 10/16/2026

    Variability in column care and buffer preparation grows as biologics processes scale. Defined, ready-to-use solutions support reproducibility across purification workflows and manufacturing scale-up.

  5. Sodium Hydroxide Solutions For Pharmaceutical Manufacturing 10/16/2026

    Outsourced sodium hydroxide preparation supports column care, pH adjustment, and CIP with multi-compendial inputs and flexible packaging, reducing on-site handling of concentrated, corrosive material.

  6. Go Further In GLP-1 Analogue Manufacturing 10/16/2026

    Manufacturing chemically synthesized GLP-1 analogues for injection means holding purity and formulation stability together, from chromatography and precipitation through tangential flow filtration.

  7. Custom Single-Use Filling Solutions For Bioprocessing 10/14/2026

    Custom single-use filling assemblies support drug-specific processes with validated components and sterility assurance, from bench-top to commercial scale.

  8. The Early Advantage For mRNA 10/9/2026

    Developing mRNA treatments requires expertise in process development and LNP encapsulation for small biotech companies.

  9. New 2X 4,000L Microbial Fermentation Capacity For Your Program Lifecycle 10/9/2026

    Two 4,000L fermenters, run singly or in parallel, extend microbial capacity at mid scale, aiming to carry a program from clinical supply through launch and commercial without changing sites.

  10. Room To Grow: Exploring The Capabilities Of 15,000L Microbial Manufacturing 10/9/2026

    Large-scale microbial fermentation raises hard questions about scale-up, primary recovery, and capacity. A 15,000L multi-product setup in Switzerland addresses them within a broader range of cGMP scales, from 70L upward.